Navigation Links
Video of EpiDerm Skin Irritation Test (SIT) Method Now Available
Date:7/23/2009

ASHLAND, Mass., July 23 /PRNewswire/ -- MatTek Corp., today announced the availability of a video version of its 2008 ECVAM-validated EpiDerm(TM) SIT non-animal alternative test method for determining the human skin irritation potential of chemicals, including cosmetic and pharmaceutical ingredients.

This 20 minute video article was published in the Journal of Visualized Experiments (JoVE). Titled, "An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model", this peer-reviewed, PubMed-indexed video article is now available for online viewing on both the MatTek (WWW.MATTEK.COM) and JoVE Web sites.

In the video, Dr. Helena Kandarova, a Senior Scientist at MatTek, demonstrates the detailed steps in the EpiDerm Skin Irritation Test (SIT) protocol. Dr. Kandarova, based in the European Union (EU), played a central role in developing this test method, which in 2007 was subjected to a blind validation trial among four EU and US-based laboratories. Dr. Kandarova noted, "The video format permits MatTek to demonstrate the procedure in great detail allowing for better understanding and faster implementation by lab personnel who are new to this type of non-animal test method."

John Sheasgreen, MatTek's President, explained the need for the video, "We knew the recent validation of the EpiDerm SIT method combined with a full ban on the use of animals for this test in the EU would create unprecedented demand from organizations worldwide for information on how to perform this test. To meet this need, we felt video was the best choice to distribute the information quickly, accurately and to as many scientists as possible."

"MatTek published in JoVE because we were impressed with JoVE's ability to produce a professional video that is peer-reviewed and indexed in PubMed," noted Dave Ingalls, Sales & Marketing Manager. "Peer-review and PubMed indexing will assure scientists that they are viewing an accurate representation of this ECVAM-validated method."

About MatTek - MatTek Corp. is the world's largest independent producer of in vitro human epithelial tissue equivalents. With over 15 years of publicly available QC data and over 400 technical references supporting our claim of "Unsurpassed Long-Term Tissue Reproducibility", MatTek human tissue equivalents are used in product development, claims substantiation (over 200 patent references cite the use of MatTek tissues), safety assessment, and drug discovery/development in many industries including Cosmetics, Personal Care, Household Products, Chemicals, Pharmaceuticals and Biotech.


'/>"/>
SOURCE MatTek Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NYU physicists find way to explore microscopic systems through holographic video
2. Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
3. Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk
4. Video: Turning Hope Into Reality - VA Research to Restore Veterans Abilities
5. Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist
6. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
7. Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimers Disease
8. Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin
9. BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on BioSpace.com
10. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
11. New Video Streaming Site Created by Ambrose Video Publishing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017   Boston Biomedical , an industry ... target cancer stemness pathways, will feature data from two ... the 2017 ASCO Gastrointestinal Cancers Symposium, held from January ... Napabucasin is an orally-administered investigational agent designed ... Cancer stem cells (CSCs) possess the property of ...
(Date:1/18/2017)... ... 2017 , ... Whitehouse Labs has furthered its efforts towards ... (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities has more ... 2017. Extractable & Leachable evaluations have become increasingly more vital to successful product ...
(Date:1/18/2017)... ... January 18, 2017 , ... BidMed, LLC, ... research and genetic testing lab equipment from two different leading institutes. This highly specialized ... regions of the United States. This 1-day online auction will take place on ...
(Date:1/18/2017)... Jan. 18, 2017  Caris Life Sciences, a ... Foundation, the largest private funder of pancreatic cancer ... evaluating the impact of immunotherapy in the treatment ... enrollment services to identify potential trial candidates based ... treating physicians and study investigators. The Lustgarten Foundation ...
Breaking Biology Technology:
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
Breaking Biology News(10 mins):